biotechnologist director physician pulmonologist biomedical engineer
Alan Brent Moy was born on April 1, 1959, in Sacramento, California. He attended Christian Brothers High School, where he developed an early interest in medicine and research and won recognition in the Westinghouse Science Talent Search. He was married to Jeanne, whom he met at Creighton University, and they had four children. Moy died at his home on April 8, 2024, after a long illness.
Moy studied biochemistry at the University of California, Davis, earning a bachelor's degree before receiving the Doctor of Medicine degree from Creighton University in 1985. He completed an internal medicine residency at St. Louis University and subsequently undertook fellowship training in pulmonary and critical care medicine at the University of Iowa. His postgraduate training supported a career combining clinical pulmonary medicine with research in vascular biology, cellular engineering, and tissue engineering.
Moy began his academic career at the University of Iowa, where he served on the faculties of the Department of Internal Medicine and the Department of Biomedical Engineering. He was an assistant professor from 1995 to 2000 and an associate professor from 2000 to 2005, conducting research in endothelial barrier function, cytoskeletal biology, vascular biology, and biomedical engineering. In industry, he founded Cellular Engineering Technologies and became its chief executive officer, leading work in stem-cell research, cell-based assays, cancer biology, bioassay development, and drug-discovery technologies. From 2005 he also practiced pulmonary medicine with Pulmonary Associates of Iowa City. Beginning in 2006, he directed the John Paul II Medical Research Institute, where he pursued regenerative-medicine research and the development of non-embryonic and ethically sourced cellular technologies. His later research included virus-free and oncogene-free induced pluripotent stem-cell reprogramming, with applications to lung disease and cell-replacement therapy.
Conducted research in regenerative medicine, vascular biology, cytoskeletal biology, tissue engineering, and cellular engineering.
Developed and studied virus-free, oncogene-free induced pluripotent stem-cell reprogramming methods using cord-blood and peripheral-blood cells, including cells from patients with lung disease.
Founded Cellular Engineering Technologies and led its development of non-embryonic stem-cell products, cell-based assays, bioassay technologies, and drug-discovery platforms.
(Co-authored experimental research on l-caldesmon gene del...)
2004(Co-authored research describing an induced pluripotent st...)
2017(Co-authored study developing a virus-free and oncogene-fr...)
2018(Co-authored research examining how histamine and thrombin...)
2002(Co-authored study of pulmonary artery endothelial barrier...)
2004(Co-authored mathematical and experimental analysis of pre...)
2007(Co-authored research on the effects of growth factors and...)
2006(Co-authored research on measurement errors and parameter ...)
2008(Co-authored research analyzing measurement artifacts in e...)
2007(Co-authored study of endothelial tension and microvascula...)
2006(International patent application listing Alan Brent Moy a...)
2005(Co-authored review discussing safety, potency, genetic st...)
2023Moy's work at the John Paul II Medical Research Institute and Cellular Engineering Technologies emphasized the development of non-embryonic and ethically sourced cellular materials for biomedical research and regenerative medicine.
Moy was a Fellow of the American College of Chest Physicians.
Moy was married to Jeanne, whom he met at Creighton University, and they had four children. He maintained interconnected academic, clinical, nonprofit, and commercial roles through the University of Iowa, Cellular Engineering Technologies, and the John Paul II Medical Research Institute.
